Summit Global Investments Purchases Shares of 6,729 iShares U.S. Pharmaceuticals ETF $IHE

Summit Global Investments purchased a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,729 shares of the company’s stock, valued at approximately $583,000. Summit Global Investments owned 0.06% of iShares U.S. Pharmaceuticals ETF as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in IHE. Foundations Investment Advisors LLC acquired a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $54,513,000. BNP Paribas Financial Markets acquired a new stake in iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth about $13,108,000. Anfield Capital Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $10,007,000. JPMorgan Chase & Co. grew its holdings in iShares U.S. Pharmaceuticals ETF by 89.4% in the 4th quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock valued at $18,052,000 after buying an additional 100,426 shares during the period. Finally, Accurate Wealth Management LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at about $6,372,000.

iShares U.S. Pharmaceuticals ETF Price Performance

NYSEARCA IHE opened at $100.64 on Thursday. iShares U.S. Pharmaceuticals ETF has a 12 month low of $64.94 and a 12 month high of $103.70. The company has a 50-day moving average of $95.11 and a 200-day moving average of $90.18. The company has a market cap of $1.44 billion, a P/E ratio of 17.75 and a beta of 0.49.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.